0001203311-19-000051.txt : 20191002 0001203311-19-000051.hdr.sgml : 20191002 20191002181229 ACCESSION NUMBER: 0001203311-19-000051 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190930 FILED AS OF DATE: 20191002 DATE AS OF CHANGE: 20191002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIMPSON TODD E CENTRAL INDEX KEY: 0001216477 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 191133665 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2019-09-30 0 0001060736 SEATTLE GENETICS INC /WA SGEN 0001216477 SIMPSON TODD E 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 Chief Financial Officer Common Stock 2019-09-30 4 S 0 15000 85.0 D 157567 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. By: /s/ Jean Liu For: Todd E. Simpson 2019-10-02